Clinical Trial Update: Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2 [Phase 2]

View source ↗

Summary

Phase 2 safety study evaluating bilateral CNTF implants in Macular Telangiectasia Type 2 has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Telangiectasia Type

Drugs mentioned

• CNTF implant (ciliary neurotrophic factor implant)

Snippet

Sponsor: Neurotech Pharmaceuticals | Conditions: Macular Telangiectasia Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2025-03-26